Study of New Imaging Criteria for the Diagnosis of Caroli's Disease
IMACA
Magnetic Resonance CholangioPancreatography Signs for the Diagnosis of Caroli Disease
1 other identifier
observational
61
1 country
1
Brief Summary
The Caroli disease is a very rare pathology that can be revealed early in childhood or in adulthood, whose diagnosis is based on Magnetic Resonance CholangioPancreatography, which shows the communication of these malformations with the rest of the biliary tree and allows to eliminate biliary stenosis. The radiologist has a central role in the diagnostic orientation between malformative intra-hepatic bile duct dilatation and obstructive benign or malignant intra-hepatic bile duct dilatation dilatation. However, imaging of Caroli disease is polymorphous and therefore subject to misinterpretation. The benefit of this research is to reduce diagnostic errors by highlighting imaging criteria specific to the Caroli disease
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 4, 2019
CompletedFirst Posted
Study publicly available on registry
July 5, 2019
CompletedStudy Start
First participant enrolled
March 18, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedNovember 16, 2021
November 1, 2021
6 months
June 4, 2019
November 15, 2021
Conditions
Outcome Measures
Primary Outcomes (6)
Intra-hepatic bile duct dilatation
study of intra-hepatic bile duct shape (qualitative measurement)
2 years
Intra-hepatic bile duct dilatation
intra-hepatic bile duct localisation (qualitative measurement)
2 years
Intra-hepatic bile duct dilatation
biliary calculi (qualitative measurement)
2 years
Intra-hepatic bile duct dilatation
dot sign (qualitative measurement)
2 years
Intra-hepatic bile duct dilatation
liver abnormalities (qualitative measurement)
2 years
Intra-hepatic bile duct dilatation
signs of portal hypertension (qualitative measurement)
2 years
Secondary Outcomes (5)
Pathological examination
2 years
Pathological examination
2 years
Biology
2 years
Biology
2 years
Biology
2 years
Interventions
The imaging data will be collected from the hospital records and image archiving system of the radiology departments of the University Hospitals
Eligibility Criteria
Patients with illness or Caroli syndrome
You may qualify if:
- were patients identified in the database of the hospitals who underwent
- a diagnosis of Caroli disease on an imaging report with bile duct dilatation limited to the intrahepatic biliary tree and
- an available Magnetic Resonance CholangioPancreatography on a Picture Archiving and Communication System.
You may not qualify if:
- obstructive benign or malignant proximal biliary stricture on Magnetic Resonance CholangioPancreatography
- prior surgical interventions for hepatobiliary disease except cholecystectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maite Lewin
Le Kremlin-Bicêtre, 94804, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
LEWIN MAITE, MD, PhD
Paul Brousse hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 4, 2019
First Posted
July 5, 2019
Study Start
March 18, 2020
Primary Completion
September 1, 2020
Study Completion
December 1, 2020
Last Updated
November 16, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share